APPENDIX A
Workshop on Screening for Thyroid Dysfunction
OCTOBER 31, 2002, IRVINE, CALIFORNIA
8:00 a.m. - Screening for Thyroid Disease - Systematic Evidence Review
Mark Helfand, M.D., M.P.H.
Oregon Health and Science University
8:40 a.m. - Thyroid Disease, Osteoporosis and Lipids in the Elderly
Douglas C. Bauer, M.D.
University of California - San Francisco
9:20 a.m. - Subclinical Thyroid Disease in a Screening Population
E. Chester Ridgway, M.D.
University of Colorado Health Sciences Center
10:00 a.m. - Break
10:30 a.m. - Thyroid Disease in the New Mexico Elder Health Survey
Robert D. Lindeman, M.D.
University of New Mexico Health Sciences Center
11:10 a.m. – Studies of Lipids and Thyroid Dysfunction
Marc Stone, M.D.
The Institute of Medicine
11:50 a.m. - Medicare Experience with Screening and Preventive Services Benefits
A. Marshall McBean, M.Sc., M.D.
University of Minnesota School of Public Health
12:30 p.m. - Lunch
1:30 p.m. - TSH Screening for Medicare - Results from a Cost-Effectiveness Model
Neil Powe, M.D., M.P.H., M.B.A.
Johns Hopkins School of Public Health
Mark Danese, Ph.D.
Amgen, Inc.
2:10 p.m. - Roundtable Discussion
3:00 p.m. - Break
3:20 p.m. - Roundtable Discussion (Continued)
4:30 p.m. - Adjournment
